by European Public Health Alliance | Oct 28, 2022 | #A2Medicines, COVID-19
By Tom Buis, Global Health Advocate at Wemos Now more than ever is the time to advocate together for structural solutions to achieve equitable access to medical products. In the upcoming months, member states of the World Health Organization (WHO) will start the...
by Rosa Castro | Oct 28, 2022 | #A2Medicines, COVID-19
7 September 2022 Thanks to the European Parliament Special Committee on the COVID-19 pandemic for this opportunity to share our feedback. We believe that meaningful engagement with civil society is key to strengthen democratic processes and improve policymaking. The...
by European Public Health Alliance | Oct 3, 2022 | #A2Medicines, COVID-19
It is undeniable that COVID-19 put a lot of pressure on the entire international health system, bringing the workload and intensity of care professionals to the extreme. Although the situation improved a lot over the last months, we cannot let our guard down and we...
by European Public Health Alliance | Sep 23, 2022 | #A2Medicines, #VaccineEquity, COVID-19, Health Inequalities
In September 2022, the European Public Health Association published a joint statement co-signed by several health NGOs, including EPHA. The purpose of this letter is to address the health emergency preparedness, learn from the pandemic, and improve the general...
by European Public Health Alliance | Apr 20, 2022 | Antimicrobial Resistance | Analysis & Opinion, COVID-19, Digital Health | Analysis & Opinion, Healthy Economic Policy | Analysis & Opinion, Non Communicable Diseases (NCDs), Universal Access and Affordable Medicines | Analysis & Opinion
The European Parliament is undertaking an extremely important task of examining how the European Union has dealt with the response to the ongoing COVID-19 pandemic. We know that its impact on almost every aspect of our lives and livelihoods has been and often...
by European Public Health Alliance | Feb 25, 2022 | COVID-19, The View from EPHA, Universal Access and Affordable Medicines | Analysis & Opinion
Guest article by Tamsin Rose, Senior Fellow for Health at Friends of Europe and former Secretary-General at EPHA COVID-19 was unprecedented but not unpredicted. In 2018, the WHO designated ‘Disease X‘ as representing the knowledge that a serious international epidemic...
